Insights

Ask Our Experts

September 19, 2023

Air quality and your health

This summer, more than 120 million Americans were under air quality alerts as smoke from Canadian wildfires drifted…

Read now

Ask Our Experts

September 19, 2023

Fall Vaccine Checklist

Last winter COVID-19, the flu, and RSV (respiratory syncytial virus) hit the population hard. Typical seasonal viral patterns…

Read now

Case Study

September 19, 2023

Living and thriving as a cancer survivor

Anne’s* boundless energy and zest for life envelops everyone around her. As a former personal fitness trainer, she…

Read now

News

August 16, 2023

PHM Launches ClearCancerIQ™, a Proprietary Predictive Tool for Employers Seeking to Improve CancerCare and Reduce Spend

PHM introduces ClearCancerIQ (CCIQ), the first-of-its-kind predictive analytics tool designed to help employers size their company’s cancer risk through quantitative analysis of their health plan population. An innovation in PHM’s ClearCancer™ suite of solutions, CCIQ enables companies to develop high impact strategies to manage cancer at both the employee and workforce level. Read now

News

July 11, 2023

Innovative treatment for prostate cancer shows long term success

PHM believes in the importance of having access to cutting-edge cancer diagnostics and therapeutics, and we are excited to announce our peer-reviewed case report in Frontiers in Oncology demonstrating why. This report summarizes the case of a 73 year-old male who went from stage 4B prostate cancer to disease free.

Our client first came to PHM after a year of his diagnosis and there were early signs that standard treatments were not going to adequately control his disease. We connected him to a clinic in Germany using theranostics, a treatment for prostate cancer that was not yet approved in the U.S. He remains disease free five years later.

Read now

Ask Our Experts

July 10, 2023

Highlighting the latest in cancer research

Each June, over 40,000 oncology professionals, including physicians, researchers, patient advocates, and pharmaceutical representatives attend the American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. This meeting is considered the premiere forum for the presentation of the most recent scientific progress made in the fight against cancer.

This year, our Chief Scientist and Senior Vice President of Research, Eva Gordon, PhD and members of our Personal Care Teams of research scientists and advanced practice clinicians attended dozens of presentations to learn the latest clinical data and emerging technologies. They also connected with oncologists, patient advocates, and technology leaders in the cancer community. Here’s some of the most exciting developments at ASCO 2023.

Read now

Case Study

July 10, 2023

Reclaiming quality of life

Larry faced debilitating back pain and struggled to live a normal life. He saw as many as five different medical experts to get relief before reaching out to PHM. Through PHM's personalized care, Larry received not only a diagnosis, treatment, and plan of action that were fast-tracked and proved successful, but also a trusted guide who helped him navigate his healthcare journey and restore his overall well-being. Read now

Ask Our Experts

July 10, 2023

Summer skin protection checklist

While our skin needs protection from the sun throughout the year, the increased time spent in the sun during the summer can raise the risk of skin damage and skin cancer.

Here is PHM’s recommended checklist on the best ways to protect yourself from the sun’s damaging UV rays and reduce your risk of developing skin cancer.

Read now

Ask Our Experts